Heterogeneity in the definition of delirium in ICUs and association with the intervention effect in randomized controlled trials: a meta-epidemiological study.


Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
04 05 2023
Historique:
received: 06 01 2023
accepted: 20 03 2023
medline: 8 5 2023
pubmed: 5 5 2023
entrez: 4 5 2023
Statut: epublish

Résumé

To evaluate the heterogeneity in the definition of delirium in randomized controlled trials (RCTs) included in meta-analyses of delirium in intensive care units (ICUs) and to explore whether intervention effect depends on the definition used. We searched PubMed for meta-analyses including RCTs evaluating prevention or treatment strategies of delirium in ICU. The definition of delirium was collected from RCTs and classified as validated (DSM criteria, CAM-ICU, ICDSC, NEECHAM, DRS-R98) or non-validated (non-validated scales, set of symptoms, physician appreciation or not reported). We conducted a meta-epidemiological analysis to compare intervention effects between trials using or not a validated definition by a two-step method as primary analysis and a multilevel model as secondary analysis. A ratio of odds ratios (ROR) < 1 indicated larger intervention effects in trials using a non-validated definition. Of 149 RCTs (41 meta-analyses), 109 (73.1%) used a validated definition and 40 (26.8%) did not (including 31 [20.8%] not reporting the definition). The primary analysis of 7 meta-analyses (30 RCTs) found no significant difference in intervention effects between trials using a validated definition and the others (ROR = 0.54, 95% CI 0.27-1.08), whereas the secondary multilevel analysis including 12 meta-analyses (67 RCTs) found significantly larger effects for trials using a non-validated versus a validated definition (ROR = 0.36, 95% CI 0.21-0.62). The definition of delirium was heterogeneous across RCTs, with one-fifth not reporting how they evaluated delirium. We did not find a significant association with intervention effect in the primary analysis. The secondary analysis including more studies revealed significantly larger intervention effects in trials using a non-validated versus a validated definition.

Identifiants

pubmed: 37143091
doi: 10.1186/s13054-023-04411-y
pii: 10.1186/s13054-023-04411-y
pmc: PMC10161412
doi:

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

170

Informations de copyright

© 2023. The Author(s).

Références

Intensive Care Med. 2009 Jul;35(7):1276-80
pubmed: 19350214
World J Psychiatry. 2012 Aug 22;2(4):58-70
pubmed: 24175169
Stat Methods Med Res. 2018 Jun;27(6):1785-1805
pubmed: 27683581
Crit Care Med. 2018 Dec;46(12):2029-2035
pubmed: 30234569
Stat Med. 2007 Jun 30;26(14):2745-58
pubmed: 17117373
BMJ. 2004 Jan 3;328(7430):22-4
pubmed: 14703540
Lancet. 2009 Jul 4;374(9683):86-9
pubmed: 19525005
Crit Care Med. 2001 Jul;29(7):1370-9
pubmed: 11445689
Lancet. 2014 Jan 11;383(9912):176-85
pubmed: 24411646
BMJ. 1997 Sep 13;315(7109):617-9
pubmed: 9310553
BMJ. 2008 Mar 15;336(7644):601-5
pubmed: 18316340
J Clin Epidemiol. 2016 Sep;77:24-37
pubmed: 27140444
Int J Older People Nurs. 2011 Jun;6(2):133-42
pubmed: 21539718
Int J Epidemiol. 2007 Aug;36(4):847-57
pubmed: 17517809
BMC Med. 2018 Jun 11;16(1):87
pubmed: 29886846
Crit Care Med. 2018 Sep;46(9):e825-e873
pubmed: 30113379
JAMA. 2001 Dec 5;286(21):2703-10
pubmed: 11730446
Crit Care. 2012 Jul 03;16(4):R115
pubmed: 22759376
Crit Care Med. 2015 Jan;43(1):40-7
pubmed: 25251759
Trials. 2021 May 20;22(1):354
pubmed: 34016134
JAMA. 2004 Apr 14;291(14):1753-62
pubmed: 15082703
JAMA. 1995 Feb 1;273(5):408-12
pubmed: 7823387
Lancet. 2014 Jan 11;383(9912):166-75
pubmed: 24411645
Nat Rev Dis Primers. 2020 Nov 12;6(1):90
pubmed: 33184265
BMJ. 2013 Apr 24;346:f2304
pubmed: 23616031
N Engl J Med. 2013 Oct 3;369(14):1306-16
pubmed: 24088092
BMJ. 2015 Mar 24;350:h809
pubmed: 25804210
Lancet. 1998 Aug 22;352(9128):609-13
pubmed: 9746022
Int J Geriatr Psychiatry. 2016 Sep;31(9):974-89
pubmed: 26898375
Stat Med. 2002 Jun 15;21(11):1513-24
pubmed: 12111917
J Intensive Care Med. 2020 Feb;35(2):107-117
pubmed: 30309280
Crit Care Med. 2020 Apr;48(4):e316-e324
pubmed: 32205622
Behav Neurol. 2015;2015:416792
pubmed: 26347584
PLoS One. 2021 Dec 2;16(12):e0259840
pubmed: 34855749
Crit Care. 2005 Aug;9(4):R375-81
pubmed: 16137350

Auteurs

Lucie Collet (L)

Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, AP-HP, Hôpital Pitié-Salpetrière, Département de Santé Publique, 47-83 Boulevard de l'Hôpital, 75013, Paris, France.
Sorbonne Université, GRC 29, DMU DREAM, AP-HP, Hôpital Pitié-Salpetrière, Département d'Anesthésie-Réanimation, Paris, France.

Aymeric Lanore (A)

Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, AP-HP, Hôpital Pitié-Salpetrière, Département de Santé Publique, 47-83 Boulevard de l'Hôpital, 75013, Paris, France.
CIC Neurosciences, Department of Neurology, Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France.

Camille Alaterre (C)

Sorbonne Université, GRC 29, DMU DREAM, AP-HP, Hôpital Pitié-Salpetrière, Département d'Anesthésie-Réanimation, Paris, France.

Jean-Michel Constantin (JM)

Sorbonne Université, GRC 29, DMU DREAM, AP-HP, Hôpital Pitié-Salpetrière, Département d'Anesthésie-Réanimation, Paris, France.

Guillaume L Martin (GL)

Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, AP-HP, Hôpital Pitié-Salpetrière, Département de Santé Publique, 47-83 Boulevard de l'Hôpital, 75013, Paris, France.

Agnès Caille (A)

Université́ de Tours, Université́ de Nantes, INSERM, SPHERE U1246, Tours, France; INSERM CIC 1415, CHRU de Tours, Tours, France.

Arthur James (A)

Sorbonne Université, GRC 29, DMU DREAM, AP-HP, Hôpital Pitié-Salpetrière, Département d'Anesthésie-Réanimation, Paris, France.

Agnès Dechartres (A)

Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, AP-HP, Hôpital Pitié-Salpetrière, Département de Santé Publique, 47-83 Boulevard de l'Hôpital, 75013, Paris, France. agnes.dechartres@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH